Capstone Holding Corp. lowers convertible note conversion price to $1.00
Investing.com - Cullinan Oncology LLC reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Cullinan Oncology LLC announced earnings per share of $-0.54 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.97 on revenue of $0.
Cullinan Oncology LLC 's are down 45% and is trading at $13.08 , still down 39.28% from its 52 week high of $21.54 set on Monday, November 15, 2021.
Cullinan Oncology LLC shares gained 6.43% to trade at $13.08 in intra-day trade the report.
Cullinan Oncology LLC follows other major Healthcare sector earnings this month
Cullinan Oncology LLC's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar